News|Articles|October 4, 2023
Using Non-Infectious MVM and RVLP Surrogates to Predict Viral ClearanceInsourcing Purification Workflows Improves Efficiency, Recovery, and Quality
Author(s)Cygnus Technologies
Non-infectious mock virus particles that mimic the physicochemical properties of live infectious viruses can be used as spiking agents during viral clearance testing.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
2
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
3
Accelerate Your Biologic with HEK Cell Lines
4